title: A comparison of trends in melanoma mortality in New Zealand and Australia: the two countries with the highest melanoma incidence and mortality in the world.
abstract: BACKGROUND
  New Zealand and Australia have the highest incidence and mortality rates from cutaneous melanoma in the world. The predominantly fair-skinned New Zealanders and Australians both enjoy sun, tanned skin and the outdoors, and differences in these activities among generations have been important determinants of trends in melanoma mortality.
  
  
  METHODS
  Five-year age-specific and age-standardised mortality rates were calculated for each country for 5-year time periods. Tests for trends in age-specific rates were performed using the Mantel-Haenszel extension chi-square test. The age-adjusted mortality rate ratios for New Zealand/Australia were plotted against period of death to show relative changes in mortality over time. Age-specific mortality rates were plotted against period and the median year of birth to illustrate age-group and birth cohort effects. To compare the mortality of birth cohorts, age-adjusted melanoma mortality rate ratios were calculated for the birth cohorts in the quin-quennial tables of mortality rates.
  
  
  RESULTS
  The age-standardised mortality rate for melanoma increased in both sexes in New Zealand and Australia from 1968 to 2007, but the increase was greater in New Zealanders and women in particular. There was evidence of recent significant decreases in mortality in younger Australians and less so in New Zealand women aged under 45 years. Mortality from melanoma increased in successive generations born from about 1893 to 1918. In Australia, a decline in mortality started for generations born from about 1958 but in New Zealand there is possibly a decrease only in generations born since 1968.
  
  
  CONCLUSIONS
  Mortality trends in New Zealand and Australia are discrepant. It is too early to know if the pattern in mortality rates in New Zealand is simply a delayed response to melanoma control activities compared with Australia, whereby we can expect the same downward trend in similar age groups in the next few years. Specific research is needed to better understand and control the increases in mortality and thickness of melanoma in New Zealand.
authors.forename: Mary Jane
authors.initials: MJ
authors.lastname: Sneyd
authors.forename: Brian
authors.initials: B
authors.lastname: Cox
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001315:Australia / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008545:Melanoma / Q000453:epidemiology* / Q000401:mortality*; D008875:Middle Aged; D009026:Mortality / Q000639:trends*; D009520:New Zealand / Q000453:epidemiology; D011379:Prognosis; D013472:Sunlight; D015996:Survival Rate; D055815:Young Adult
references.citation: Br J Dermatol. 2007 May;156(5):938-44
references.pmid: 17381454
references.citation: Eur J Cancer. 2009 Sep;45(13):2360-6
references.pmid: 19375307
references.citation: Br J Cancer. 2000 Jun;82(11):1887-91
references.pmid: 10839308
references.citation: Br J Cancer. 2006 Jul 3;95(1):91-5
references.pmid: 16755289
references.citation: Int J Cancer. 2000 May 20;89(3):271-9
references.pmid: 10861504
references.citation: J Am Acad Dermatol. 2007 Oct;57(4):555-72; quiz 573-6
references.pmid: 17870429
references.citation: Int J Cancer. 1983 Jun 15;31(6):715-8
references.pmid: 6862682
references.citation: Br J Prev Soc Med. 1956 Oct;10(4):159-71
references.pmid: 13396199
references.citation: Melanoma Res. 2004 Aug;14(4):301-9
references.pmid: 15305162
references.citation: Soc Sci Med. 2001 Nov;53(9):1175-89
references.pmid: 11556608
references.citation: Cancer. 2009 Mar 15;115(6):1318-27
references.pmid: 19189368
references.citation: Health Educ Behav. 2001 Jun;28(3):290-305
references.pmid: 11380050
references.citation: Cancer Causes Control. 2006 Feb;17(1):21-7
references.pmid: 16411049
references.citation: J Am Acad Dermatol. 2006 May;54(5):783-92
references.pmid: 16635658
references.citation: Cancer Detect Prev. 1996;20(3):245-50
references.pmid: 8769719
references.citation: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references.pmid: 21685461
references.citation: Cancer. 2006 Sep 15;107(6):1331-9
references.pmid: 16909413
references.citation: Aust N Z J Public Health. 2005 Aug;29(4):383-6
references.pmid: 16222938
references.citation: Tumori. 2005 Jan-Feb;91(1):6-8
references.pmid: 15849997
references.citation: Int J Cancer. 2012 Jan 1;130(1):170-8
references.pmid: 21344376
references.citation: Cancer. 2011 Jun 1;117(11):2489-98
references.pmid: 24048797
references.citation: Int J Cancer. 1980 Dec 15;26(6):703-9
references.pmid: 7216539
references.citation: Int J Cancer. 2008 Feb 15;122(4):905-8
references.pmid: 17957799
references.citation: Arch Dermatol. 1999 Mar;135(3):269-74
references.pmid: 10086447
references.citation: Int J Cancer. 2000 May 20;89(3):280-5
references.pmid: 10861505
references.citation: Br J Cancer. 2007 Jun 4;96(11):1772-7
references.pmid: 17533392